• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能放射组学预测ⅠA 期肺癌患者的早期复发。

Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.

机构信息

Department of Thoracic Surgery, Tokyo Medical University, Tokyo, Japan.

Department of Radiology, Tokyo Medical University, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2022 Dec;29(13):8185-8193. doi: 10.1245/s10434-022-12516-x. Epub 2022 Sep 7.

DOI:10.1245/s10434-022-12516-x
PMID:36070112
Abstract

BACKGROUND

We seek to explore the ability of computed tomography (CT)-based radiomics coupled with artificial intelligence (AI) to predict early recurrence (< 2 years after surgery) in patients with clinical stage 0-IA non-small cell lung cancer (c-stage 0-IA NSCLC).

PATIENTS AND METHODS

Data of 642 patients were collected for early recurrence and assigned to the derivation and validation cohorts at a ratio of 2:1. Using the AI software Beta Version (Fujifilm Corporation, Japan), 39 AI imaging factors, including 17 factors from the AI ground-glass nodule analysis and 22 radiomic features from nodule characterization analysis, were extracted.

RESULTS

Multivariate analysis showed that male sex (p = 0.016), solid part size (p < 0.001), CT value standard deviation (p = 0.038), solid part volume ratio (p = 0.016), and bronchus translucency (p = 0.007) were associated with recurrence-free survival (RFS). Receiver operating characteristics analysis showed that the area under the curve and optimal cutoff values relevant to recurrence were 0.707 and 1.49 cm for solid part size, and 0.710 and 22.9% for solid part volume ratio, respectively. The 5-year RFS rates for patients in the validation set with solid part size ≤ 1.49 cm and > 1.49 cm were 92.2% and 70.4% (p < 0.001), whereas those for patients with solid part volume ratios ≤ 22.9% and > 22.9% were 97.8% and 71.7% (p < 0.001), respectively.

CONCLUSIONS

CT-based radiomics coupled with AI contributes to the noninvasive prediction of early recurrence in patients with c-stage 0-IA NSCLC.

摘要

背景

我们旨在探索基于计算机断层扫描(CT)的放射组学与人工智能(AI)相结合,预测临床分期 0-IA 期非小细胞肺癌(c 分期 0-IA NSCLC)患者的早期复发(术后<2 年)。

患者与方法

收集了 642 例患者的早期复发数据,并按照 2:1 的比例将其分配到推导和验证队列中。使用 AI 软件 Beta Version(富士胶片公司,日本)提取了 39 个 AI 成像因素,包括 AI 磨玻璃结节分析的 17 个因素和结节特征分析的 22 个放射组学特征。

结果

多变量分析表明,男性(p=0.016)、实性部分大小(p<0.001)、CT 值标准差(p=0.038)、实性部分体积比(p=0.016)和支气管透明度(p=0.007)与无复发生存率(RFS)相关。受试者工作特征分析显示,与复发相关的曲线下面积和最佳截断值分别为 1.49cm 时的实性部分大小为 0.707,实性部分体积比为 0.710 和 22.9%。验证队列中实性部分大小≤1.49cm 和>1.49cm 的患者 5 年 RFS 率分别为 92.2%和 70.4%(p<0.001),而实性部分体积比≤22.9%和>22.9%的患者 5 年 RFS 率分别为 97.8%和 71.7%(p<0.001)。

结论

基于 CT 的放射组学与 AI 相结合有助于预测 c 分期 0-IA NSCLC 患者的早期复发。

相似文献

1
Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.人工智能放射组学预测ⅠA 期肺癌患者的早期复发。
Ann Surg Oncol. 2022 Dec;29(13):8185-8193. doi: 10.1245/s10434-022-12516-x. Epub 2022 Sep 7.
2
Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer.基于人工智能的影像组学在预测早期肺癌淋巴结转移中的应用。
Sci Rep. 2023 Jan 19;13(1):1028. doi: 10.1038/s41598-023-28242-7.
3
Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers.人工智能分析三维成像数据得出与影像学表现为实性为主的小尺寸肺癌患者术后复发相关的因素。
Eur J Cardiothorac Surg. 2022 Mar 24;61(4):751-760. doi: 10.1093/ejcts/ezab541.
4
Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.基于影像组学的临床和病理ⅠA 期纯磨玻璃密度非小细胞肺癌生存风险分层。
Radiology. 2022 Feb;302(2):425-434. doi: 10.1148/radiol.2021210109. Epub 2021 Nov 2.
5
Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.基于术前 CT 分期 IA 期非小细胞肺癌的预测放射组学模型的建立:淋巴结转移。
Lung Cancer. 2020 Jan;139:73-79. doi: 10.1016/j.lungcan.2019.11.003. Epub 2019 Nov 9.
6
Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.正电子发射断层扫描上的肿瘤标准化摄取值是薄层计算机断层扫描显示部分实性结节的c期IA期肺癌患者原位腺癌的一种新的预测指标。
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):329-34. doi: 10.1093/icvts/ivt500. Epub 2013 Dec 18.
7
Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.实性为主的临床I A期非小细胞肺癌中磨玻璃影小成分的临床影响
J Thorac Cardiovasc Surg. 2022 Mar;163(3):791-801.e4. doi: 10.1016/j.jtcvs.2020.12.089. Epub 2020 Dec 29.
8
Radiomics Signature Predicts the Recurrence-Free Survival in Stage I Non-Small Cell Lung Cancer.放射组学特征预测 I 期非小细胞肺癌无复发生存。
Ann Thorac Surg. 2020 Jun;109(6):1741-1749. doi: 10.1016/j.athoracsur.2020.01.010. Epub 2020 Feb 20.
9
Predicting recurrence of non-small cell lung cancer based on mean computed tomography value.基于平均 CT 值预测非小细胞肺癌的复发。
J Cardiothorac Surg. 2021 May 12;16(1):128. doi: 10.1186/s13019-021-01476-0.
10
The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non-Small Cell Lung Cancer.临床ⅠA 期非小细胞肺癌患者肿瘤体积的预后影响。
J Thorac Oncol. 2016 Jul;11(7):1074-80. doi: 10.1016/j.jtho.2016.02.005. Epub 2016 Feb 18.

引用本文的文献

1
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.人工智能在肺癌临床应用的全面综述
Cancers (Basel). 2025 Mar 4;17(5):882. doi: 10.3390/cancers17050882.
2
A Comprehensive Review on the Application of Artificial Intelligence for Predicting Postsurgical Recurrence Risk in Early-Stage Non-Small Cell Lung Cancer Using Computed Tomography, Positron Emission Tomography, and Clinical Data.关于使用计算机断层扫描、正电子发射断层扫描和临床数据,应用人工智能预测早期非小细胞肺癌术后复发风险的综合综述。
J Med Radiat Sci. 2025 Jan 23. doi: 10.1002/jmrs.860.
3
Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis.

本文引用的文献

1
Preoperative inflammation-based scores predict early recurrence after lung cancer resection.基于术前炎症的评分可预测肺癌切除术后的早期复发。
J Thorac Dis. 2021 May;13(5):2812-2823. doi: 10.21037/jtd-20-3458.
2
Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.基于术前 CT 分期 IA 期非小细胞肺癌的预测放射组学模型的建立:淋巴结转移。
Lung Cancer. 2020 Jan;139:73-79. doi: 10.1016/j.lungcan.2019.11.003. Epub 2019 Nov 9.
3
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges.
人工智能在肺癌筛查中的应用:检测、分类、预测和预后。
Cancer Med. 2024 Apr;13(7):e7140. doi: 10.1002/cam4.7140.
4
CT radiomics for predicting the prognosis of patients with stage II rectal cancer during the three-year period after surgery, chemotherapy and radiotherapy.CT影像组学用于预测II期直肠癌患者术后、化疗及放疗后三年期间的预后。
Heliyon. 2023 Dec 27;10(1):e23923. doi: 10.1016/j.heliyon.2023.e23923. eCollection 2024 Jan 15.
5
CT-Derived Body Composition Is a Predictor of Survival after Esophagectomy.CT衍生的身体成分是食管癌切除术后生存的预测指标。
J Clin Med. 2023 Mar 8;12(6):2106. doi: 10.3390/jcm12062106.
放射组学在肿瘤精准诊断与治疗中的应用:机遇与挑战。
Theranostics. 2019 Feb 12;9(5):1303-1322. doi: 10.7150/thno.30309. eCollection 2019.
4
Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.肿瘤实性成分的体积定量分析与 3DCT 和 FDG-PET 成像在临床ⅠA 期肺腺癌中的预后价值。
Lung Cancer. 2018 Jul;121:91-96. doi: 10.1016/j.lungcan.2018.05.001. Epub 2018 May 4.
5
Radiomics and radiogenomics in lung cancer: A review for the clinician.肺癌的影像组学和放射组学:临床医生的综述。
Lung Cancer. 2018 Jan;115:34-41. doi: 10.1016/j.lungcan.2017.10.015. Epub 2017 Nov 8.
6
Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.磨玻璃影成分对非小细胞肺癌临床 T 分期的预后影响。
J Thorac Cardiovasc Surg. 2017 Dec;154(6):2102-2110.e1. doi: 10.1016/j.jtcvs.2017.08.037. Epub 2017 Sep 1.
7
Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer.磨玻璃影成分在临床IA期放射学浸润性肺癌中的重要性
Ann Thorac Surg. 2017 Jul;104(1):313-320. doi: 10.1016/j.athoracsur.2017.01.076. Epub 2017 Apr 19.
8
Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.通过氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描综合分期的临床I期非小细胞肺癌患者隐匿性淋巴结转移的预测危险因素
World J Surg. 2016 Dec;40(12):2976-2983. doi: 10.1007/s00268-016-3652-5.
9
Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.在部分实性肺癌中,最大肿瘤大小和实性成分大小均无预后价值:肿瘤大小的影响应仅适用于实性肺癌。
Ann Thorac Surg. 2016 Aug;102(2):407-15. doi: 10.1016/j.athoracsur.2016.02.074. Epub 2016 May 11.
10
Lymph node metastasis in clinical stage IA peripheral lung cancer.临床ⅠA 期周围型肺癌的淋巴结转移。
Lung Cancer. 2015 Oct;90(1):41-6. doi: 10.1016/j.lungcan.2015.07.003. Epub 2015 Jul 11.